NKG2D is a key receptor for recognition of bladder cancer cells by IL-2-activated NK cells and BCG promotes NK cell activation

Frontiers in Immunology

Volumn 6, Issue JUN, 2015, Pages

  García Cuesta, Eva María ^a   López Cobo, Sheila ^a   Álvarez Maestro, Mario ^b   Esteso, Gloria ^a   Romera Cárdenas, Gema ^a   Rey, Mercedes ^a,e   Cassady Cain, Robin L ^c,f   Linares, Ana ^b   Valés Gómez, Alejandro ^d   Reyburn, Hugh Thomson ^a   Martínez Piñeiro, Luis ^b   Valés Gómez, Mar ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d Jobssy SL   (Spain)

^e HOSPITAL DONOSTIA   (Spain)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Bladder cancer; Mycobacterium bovis; Natural cytotoxicity receptors; Natural killer cells; NKG2D

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; MITOMYCIN; NATURAL KILLER CELL RECEPTOR NKG2D;

AGED; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER DIAGNOSIS; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DEGRANULATION ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; MYCOBACTERIUM BOVIS BCG; PROTEIN EXPRESSION;

EID: 84935065126     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00284     Document Type: Article

References (43)

1. Kurth KH, Bouffioux C, Sylvester R, Van Der Meijden AP, Oosterlinck W, Brausi M. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group. Eur Urol (2000) 37(Suppl 3):1-9. doi: 10.1159/000052386
2. Luo Y, Henning J, O'Donnell MA. Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guerin and prospective use in immunotherapy of bladder cancer. Clin Dev Immunol (2011) 2011:728930. doi:10.1155/2011/728930
3. Gandhi NM, Morales A, Lamm DL. Bacillus Calmette-Guerin immunotherapy for genitourinary cancer. BJU Int (2013) 112:288-97. doi:10.1111/j.1464-410X.2012.11754.x
4. Brandau S, Suttmann H, Riemensberger J, Seitzer U, Arnold J, Durek C, et al. Perforin-mediated lysis of tumor cells by Mycobacterium bovis bacillus Calmette-Guerin-activated killer cells. Clin Cancer Res (2000) 6:3729-38.
5. Brandau S, Bohle A. Activation of natural killer cells by bacillus Calmette-Guerin. Eur Urol (2001) 39:518-24. doi:10.1159/000052497
6. Brandau S, Riemensberger J, Jacobsen M, Kemp D, Zhao W, Zhao X, et al. NK cells are essential for effective BCG immunotherapy. Int J Cancer (2001) 92:697-702. doi:10.1002/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z
7. Suttmann H, Jacobsen M, Reiss K, Jocham D, Bohle A, Brandau S. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation. J Urol (2004) 172:1490-5. doi:10.1097/01.ju.0000131944.52354.63
8. Naoe M, Ogawa Y, Takeshita K, Morita J, Iwamoto S, Miyazaki A, et al. Bacillus Calmette-Guerin-pulsed dendritic cells stimulate natural killer T cells and gammadeltaT cells. Int J Urol (2007) 14:532-8. doi:10.1111/j.1442-2042.2006.01697.x
9. Higuchi T, Shimizu M, Owaki A, Takahashi M, Shinya E, Nishimura T, et al. A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth. Cancer Immunol Immunother (2009) 58:1245-55. doi:10.1007/s00262-008-0643-x
10. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science (2011) 331:44-9. doi:10.1126/science.1198687
11. Campbell KS, Hasegawa J. Natural killer cell biology: an update and future directions. J Allergy Clin Immunol (2013) 132:536-44. doi:10.1016/j.jaci.2013.07.006
12. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 31:227-58. doi:10.1146/annurev-immunol-020711-075005
13. Perez-Villar JJ, Melero I, Navarro F, Carretero M, Bellon T, Llano M, et al. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol (1997) 158:5736-43.
14. Giacomini P, Beretta A, Nicotra MR, Ciccarelli G, Martayan A, Cerboni C, et al. HLA-C heavy chains free of beta2-microglobulin: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-gamma responsiveness. Tissue Antigens (1997) 50:555-66. doi:10.1111/j.1399-0039.1997.tb02913.x
15. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature (2001) 409:1055-60. doi:10.1038/35059110
16. Chisholm SE, Reyburn HT. Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors. J Virol (2006) 80:2225-33. doi:10.1128/JVI.80.5.2225-2233.2006
17. Vales-Gomez M, Browne H, Reyburn HT. Expression of the UL16 glycoprotein of human cytomegalovirus protects the virus-infected cell from attack by natural killer cells. BMC Immunol (2003) 4:4. doi:10.1186/1471-2172-4-4
18. Bubenik J, Baresova M, Viklicky V, Jakoubkova J, Sainerova H, Donner J. Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int J Cancer (1973) 11:765-73. doi:10.1002/ijc.2910110327
19. Grossman HB, Wedemeyer G, Ren L, Wilson GN, Cox B. Improved growth of human urothelial carcinoma cell cultures. J Urol (1986) 136:953-9.
20. O'Toole C, Price ZH, Ohnuki Y, Unsgaard B. Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma. Br J Cancer (1978) 38:64-76. doi:10.1038/bjc.1978.164
21. Masters JR, Hepburn PJ, Walker L, Highman WJ, Trejdosiewicz LK, Povey S, et al. Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res (1986) 46:3630-6.
22. Kyriazis AA, Kyriazis AP, McCombs WB III, Peterson WD Jr. Morphological, biological, and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and in nude mice. Cancer Res (1984) 44:3997-4005.
23. Ito M, Maruyama T, Saito N, Koganei S, Yamamoto K, Matsumoto N. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med (2006) 203:289-95. doi:10.1084/jem.20051986
24. Voehringer D, Koschella M, Pircher H. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood (2002) 100:3698-702. doi:10.1182/blood-2002-02-0657
25. Schweier O, Hofmann M, Pircher H. KLRG1 activity is regulated by association with the transferrin receptor. Eur J Immunol (2014) 44:1851-6. doi:10.1002/eji.201344234
26. Helander TS, Timonen T. Adhesion in NK cell function. Curr Top Microbiol Immunol (1998) 230:89-99.
27. Bryceson YT, Ljunggren HG, Long EO. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood (2009) 114:2657-66. doi:10.1182/blood-2009-01-201632
28. Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, Ruggeri L, et al. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J Clin Invest (2009) 119:1251-63. doi:10.1172/JCI36022
29. Chan CJ, Andrews DM, McLaughlin NM, Yagita H, Gilfillan S, Colonna M, et al. DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases. J Immunol (2010) 184:902-11. doi:10.4049/jimmunol.0903225
30. Barber DF, Long EO. Coexpression of CD58 or CD48 with intercellular adhesion molecule 1 on target cells enhances adhesion of resting NK cells. J Immunol (2003) 170:294-9. doi:10.4049/jimmunol.170.1.294
31. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol (1990) 8:365-400. doi:10.1146/annurev.iy.08.040190.002053
32. Hedges S, Agace W, Svensson M, Sjogren AC, Ceska M, Svanborg C. Uroepithelial cells are part of a mucosal cytokine network. Infect Immun (1994) 62:2315-21.
33. Miyazaki J, Kawai K, Oikawa T, Johraku A, Hattori K, Shimazui T, et al. Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette-Guerin through toll-like receptor signalling. BJU Int (2006) 97:860-4. doi:10.1111/j.1464-410X.2006.06026.x
34. Das H, Groh V, Kuijl C, Sugita M, Morita CT, Spies T, et al. MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity (2001) 15:83-93. doi:10.1016/S1074-7613(01)00168-6
35. Dai Z, Turtle CJ, Booth GC, Riddell SR, Gooley TA, Stevens AM, et al. Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus. J Exp Med (2009) 206:793-805. doi:10.1084/jem.20081648
36. Huergo-Zapico L, Acebes-Huerta A, Gonzalez-Rodriguez AP, Contesti J, Gonzalez-Garcia E, Payer AR, et al. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease. PLoS One (2014) 9:e108326. doi:10.1371/journal.pone.0108326
37. Tessmer MS, Fugere C, Stevenaert F, Naidenko OV, Chong HJ, Leclercq G, et al. KLRG1 binds cadherins and preferentially associates with SHIP-1. Int Immunol (2007) 19:391-400. doi:10.1093/intimm/dxm004
38. Banh C, Fugere C, Brossay L. Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling. Blood (2009) 114:5299-306. doi:10.1182/blood-2009-06-228353
39. Bryceson YT, March ME, Ljunggren HG, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood (2006) 107:159-66. doi:10.1182/blood-2005-04-1351
40. Yutkin V, Pode D, Pikarsky E, Mandelboim O. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study. J Urol (2007) 178:2660-4. doi:10.1016/j.juro.2007.07.118
41. Chan CJ, Martinet L, Gilfillan S, Souza-Fonseca-Guimaraes F, Chow MT, Town L, et al. The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nat Immunol (2014) 15:431-8. doi:10.1038/ni.2850
42. Vankayalapati R, Garg A, Porgador A, Griffith DE, Klucar P, Safi H, et al. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol (2005) 175:4611-7. doi:10.4049/jimmunol.175.7.4611
43. Shafi S, Vantourout P, Wallace G, Antoun A, Vaughan R, Stanford M, et al. An NKG2D-mediated human lymphoid stress surveillance response with high interindividual variation. Sci Transl Med (2011) 3:113ra124. doi:10.1126/scitranslmed.3002922